New preclinical research shows promise for a potential treatment pathway aimed at slowing the disease process and extending survival in patients with ALS, often called Lou Gehrig’s disease, an insidious neurological condition. The research by University of Florida neurogeneticists Laura Ranum, Ph.D., and Lien Nguyen, Ph.D.; Neurimmune; Biogen; and collaborators at Johns Hopkins University shows that targeting a specific mutant protein in the brain with a human-derived antibody can lower neuroinflammation, slow neurodegeneration and lengthen survival in the most common genetic form of amyotrophic lateral sclerosis, or ALS, and frontotemporal dementia, or FTD....continue reading

Clinical care and research in the UF Department of Obstetrics and Gynecology recognizes that women who experience preeclampsia — and the offspring of those pregnancies — are at higher risk of cardiovascular disease and other problems later in life....continue reading

A study at UF Health provides the first contemporary evidence that among patients who form uric acid stones, those who adhere to potassium citrate therapy have smaller recurrence sizes and fewer repeat surgical interventions than those who decline the medication, cannot tolerate it or cannot access it....continue reading

UF Health is the only center in the Southeast that consistently performs a potentially restorative procedure for patients with obstructive aphagia, or complete esophageal lumen occlusion....continue reading